Bogle Investment Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-94,559
Closed -$13.8M 369
2019
Q1
$13.8M Buy
94,559
+4,600
+5% +$667K 1.06% 12
2018
Q4
$12M Buy
+89,959
New +$14.7M 0.94% 32
2018
Q1
Sell
-62,283
Closed -$10.2M 420
2017
Q4
$10.2M Buy
+62,283
New +$11.2M 0.75% 56
2016
Q3
Sell
-28,558
Closed -$6.6M 491
2016
Q2
$6.6M Buy
+28,558
New +$6.58M 0.46% 83

Other funds holding AGN

Bogle Investment Management's AGN Position: Q2 2019 in Review

Bogle Investment Management sold out of Allergan plc (AGN) in Q2 2019, closing a stake of 94,559 shares — an estimated $13.8M sold.

Bogle Investment Management first reported a position in AGN in Q2 2016 and held it in 4 quarters. The position peaked at $13.8M in Q1 2019. 971 funds tracked by Wall St. Rank hold AGN as of Q2 2019.

  • Bogle Investment Management reported no remaining Allergan plc position as of Q2 2019 after selling out during the quarter.
  • Bogle Investment Management sold 94,559 Allergan plc shares in Q2 2019, an estimated $13.8M.
  • Bogle Investment Management first reported a position in Allergan plc in Q2 2016 and held it in 4 quarters.
  • Bogle Investment Management's Allergan plc position peaked at $13.8M in Q1 2019.
  • 971 funds tracked by Wall St. Rank held Allergan plc as of Q2 2019.

Based on Bogle Investment Management's 13F filing for Q2 2019, filed 13 Aug 2019.